Literature DB >> 10706524

Associations of tibial lead levels with BsmI polymorphisms in the vitamin D receptor in former organolead manufacturing workers.

B S Schwartz1, W F Stewart, K T Kelsey, D Simon, S Park, J M Links, A C Todd.   

Abstract

We evaluated associations of tibial lead levels with polymorphisms in the vitamin D receptor (VDR) in 504 former organolead manufacturing workers with past exposure to lead. In this cross-sectional study, we measured tibial lead by (109)Cd K-shell X-ray fluorescence. Tibial lead was evaluated in subjects with different VDR genotypes defined using the BsmI restriction enzyme, adjusting for confounding variables. Study participants had a mean age +/- SD of 57.4 +/- 7.6 years. A total of 169 (33.5%) subjects were homozygous for the BsmI restriction site (designated bb), 251 (49.8%) were heterozygous (Bb), and 84 (16.7%) were homozygous for the absence of the restriction site (BB). Among all of the study subjects, tibial lead concentrations were low, with a mean +/- SD of 14.4 +/- 9.3 microg Pb/g bone mineral. There were only small differences in tibial lead concentrations by VDR genotype, with mean +/- SD tibial lead concentrations of 13.9 +/- 7.9, 14.3 +/- 9.5, and 15.5 +/- 11.1 in subjects with bb, Bb, and BB, respectively. In a multiple linear regression model of tibial lead concentrations, the VDR genotype modified the relation between age and tibial lead concentrations; subjects with the B allele had larger increases in tibial lead concentrations with increasing age (0.37, 0.48, and 0.67 microg/g per year of age in subjects with bb, Bb, and BB, respectively; the adjusted p-value for trend in slopes = 0.04). The VDR genotype also modified the relation between years since last exposure to lead and tibial lead concentrations. Subjects with bb evidenced an average decline in tibial lead concentrations of 0.10 microg/g per year since their last exposure to lead, whereas subjects with Bb and BB evidenced average increases of 0.03 and 0.11 microg/g per year, respectively (the adjusted p-value for trend in slopes = 0.01). Polymorphisms in the vitamin D receptor modified the relations of age and years since the last exposure to lead with tibial lead concentrations. Although controversy remains on the influence of the VDR genotype on bone mineral density, the data suggest that variant VDR alleles modify lead concentrations in bone, either by influencing lead content or calcium content or both.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10706524      PMCID: PMC1637981          DOI: 10.1289/ehp.00108199

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  29 in total

1.  Age and secular trends in bone lead levels in middle-aged and elderly men: three-year longitudinal follow-up in the Normative Aging Study.

Authors:  R Kim; C Landrigan; P Mossmann; D Sparrow; H Hu
Journal:  Am J Epidemiol       Date:  1997-10-01       Impact factor: 4.897

2.  X-ray fluorescence: issues surrounding the application of a new tool for measuring burden of lead.

Authors:  H Hu; F L Milder; D E Burger
Journal:  Environ Res       Date:  1989-08       Impact factor: 6.498

3.  Mobilization of lead from the skeleton during the postnatal period is larger than during pregnancy.

Authors:  B L Gulson; K R Mahaffey; C W Jameson; K J Mizon; M J Korsch; M A Cameron; J A Eisman
Journal:  J Lab Clin Med       Date:  1998-04

4.  Blood lead levels and dietary calcium intake in 1- to 11-year-old children: the Second National Health and Nutrition Examination Survey, 1976 to 1980.

Authors:  K R Mahaffey; P S Gartside; C J Glueck
Journal:  Pediatrics       Date:  1986-08       Impact factor: 7.124

5.  Comparison of two in vitro methods of bone lead analysis and the implications for in vivo measurements.

Authors:  L J Somervaille; D R Chettle; M C Scott; A C Aufderheide; J E Wallgren; L E Wittmers; G R Rapp
Journal:  Phys Med Biol       Date:  1986-11       Impact factor: 3.609

6.  Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent.

Authors:  J Sainz; J M Van Tornout; M L Loro; J Sayre; T F Roe; V Gilsanz
Journal:  N Engl J Med       Date:  1997-07-10       Impact factor: 91.245

7.  Effect of lead ingestion on functions of vitamin D and its metabolites.

Authors:  C M Smith; H F DeLuca; Y Tanaka; K R Mahaffey
Journal:  J Nutr       Date:  1981-08       Impact factor: 4.798

8.  Neurobehavioral function and tibial and chelatable lead levels in 543 former organolead workers.

Authors:  W F Stewart; B S Schwartz; D Simon; K I Bolla; A C Todd; J Links
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

9.  Predictors of dimercaptosuccinic acid chelatable lead and tibial lead in former organolead manufacturing workers.

Authors:  B S Schwartz; W F Stewart; A C Todd; J M Links
Journal:  Occup Environ Med       Date:  1999-01       Impact factor: 4.402

10.  Intestinal lead and calcium absorption: effect of 1,25-dihydroxycholecalciferol and lead status.

Authors:  C S Fullmer
Journal:  Proc Soc Exp Biol Med       Date:  1990-07
View more
  24 in total

1.  Functional principal component model for high-dimensional brain imaging.

Authors:  Vadim Zipunnikov; Brian Caffo; David M Yousem; Christos Davatzikos; Brian S Schwartz; Ciprian Crainiceanu
Journal:  Neuroimage       Date:  2011-06-21       Impact factor: 6.556

2.  Genetic diversity influences the response of the brain to developmental lead exposure.

Authors:  Jay S Schneider; Keyur Talsania; William Mettil; David W Anderson
Journal:  Toxicol Sci       Date:  2014-06-09       Impact factor: 4.849

3.  Multilevel Functional Principal Component Analysis for High-Dimensional Data.

Authors:  Vadim Zipunnikov; Brian Caffo; David M Yousem; Christos Davatzikos; Brian S Schwartz; Ciprian Crainiceanu
Journal:  J Comput Graph Stat       Date:  2011       Impact factor: 2.302

4.  Effects of chloro-s-triazine herbicides and metabolites on aromatase activity in various human cell lines and on vitellogenin production in male carp hepatocytes.

Authors:  J T Sanderson; R J Letcher; M Heneweer; J P Giesy; M van den Berg
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

Review 5.  Dietary calcium supplementation to lower blood lead levels in pregnancy and lactation.

Authors:  Adrienne S Ettinger; Howard Hu; Mauricio Hernandez-Avila
Journal:  J Nutr Biochem       Date:  2007-03       Impact factor: 6.048

6.  Herbal supplement use and blood lead levels of United States adults.

Authors:  Catherine Buettner; Kenneth J Mukamal; Paula Gardiner; Roger B Davis; Russell S Phillips; Murray A Mittleman
Journal:  J Gen Intern Med       Date:  2009-07-03       Impact factor: 5.128

7.  Gender and race/ethnicity differences in lead dose biomarkers.

Authors:  Keson Theppeang; Thomas A Glass; Karen Bandeen-Roche; Andrew C Todd; Charles A Rohde; Brian S Schwartz
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

Review 8.  The role of genetic polymorphisms in environmental health.

Authors:  Samir N Kelada; David L Eaton; Sophia S Wang; Nathaniel R Rothman; Muin J Khoury
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

9.  Associations of renal function with polymorphisms in the delta-aminolevulinic acid dehydratase, vitamin D receptor, and nitric oxide synthase genes in Korean lead workers.

Authors:  Virginia M Weaver; Brian S Schwartz; Kyu-Dong Ahn; Walter F Stewart; Karl T Kelsey; Andrew C Todd; Jiayu Wen; David J Simon; Mark E Lustberg; Patrick J Parsons; Ellen K Silbergeld; Byung-Kook Lee
Journal:  Environ Health Perspect       Date:  2003-10       Impact factor: 9.031

10.  Vitamin D receptor Fok1 polymorphism and blood lead concentration in children.

Authors:  Erin N Haynes; Heidi J Kalkwarf; Richard Hornung; Richard Wenstrup; Kim Dietrich; Bruce P Lanphear
Journal:  Environ Health Perspect       Date:  2003-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.